| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.0081 | 0.9 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |